Tivic Health Systems, Inc.
TIVCNASDAQHealthcare● Active
$0.65
$-0.01(-1.83%)
Market Cap$698701
P/E Ratio—
52W High$5.6
52W Low$0.645
Tivic Health Systems, Inc. (TIVC) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
TIVC · earnings · updated Jun 9, 2026
Latest Earnings
Q2 FY2026Report Date: Apr 1, 2026EPS Actual
-$2.23
Est. -$408.00 · +99.5%
Revenue
—
Est. $0.00B
Fiscal Period
Q2 FY2026
FY ends December
Report Date
Apr 1, 2026
After Market Close
▲ Beat EPS🔥 8-Quarter EPS Beat Streak
TIVC reports quarterly as a NASDAQ-listed Medical - Devices company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ▲ Q2 FY2026 | Apr 1, 2026 | -$408.00 | -$2.23 | +99.5% | — | $0.00B | — |
| — Q1 FY2026 | Mar 25, 2026 | — | -$0.90 | — | $-0.00B | — | — |
| — Q4 FY2025 | Nov 14, 2025 | — | -$1.97 | — | $0.00B | — | — |
| — Q3 FY2025 | Aug 14, 2025 | — | -$2.19 | — | $0.00B | — | — |
| — Q2 FY2025 | May 15, 2025 | — | -$2.52 | — | $0.00B | — | — |
| ▲ Q1 FY2025 | Mar 21, 2025 | -$85.00 | -$15.42 | +81.9% | $0.00B | $0.00B | -87.4% |
| ▲ Q4 FY2024 | Nov 14, 2024 | -$102.00 | -$3.91 | +96.2% | $0.00B | $0.00B | -90.0% |
| ▲ Q3 FY2024 | Aug 14, 2024 | -$102.00 | -$5.44 | +94.7% | $0.00B | $0.00B | -87.6% |
Q2 FY2026
Apr 1, 2026Beat
EPS Actual
-$2.23
EPS Est.
-$408.00
EPS Surpr.
+99.5%
Revenue
—
Q1 FY2026
Mar 25, 2026
EPS Actual
-$0.90
EPS Est.
—
EPS Surpr.
—
Revenue
$-0.00B
Q4 FY2025
Nov 14, 2025
EPS Actual
-$1.97
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q3 FY2025
Aug 14, 2025
EPS Actual
-$2.19
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q2 FY2025
May 15, 2025
EPS Actual
-$2.52
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q1 FY2025
Mar 21, 2025Beat
EPS Actual
-$15.42
EPS Est.
-$85.00
EPS Surpr.
+81.9%
Revenue
$0.00B
Q4 FY2024
Nov 14, 2024Beat
EPS Actual
-$3.91
EPS Est.
-$102.00
EPS Surpr.
+96.2%
Revenue
$0.00B
Q3 FY2024
Aug 14, 2024Beat
EPS Actual
-$5.44
EPS Est.
-$102.00
EPS Surpr.
+94.7%
Revenue
$0.00B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q3 FY2028 | $-85.00 | $-85.00 | $-85.00 | 1 |
| Q2 FY2028 | $-102.00 | $-102.00 | $-102.00 | 1 |
| Q1 FY2028 | $-102.00 | $-102.00 | $-102.00 | 1 |
| Q4 FY2027 | $-119.00 | $-119.00 | $-119.00 | 1 |
| Q3 FY2027 | $-119.00 | $-119.00 | $-119.00 | 1 |
| Q2 FY2027 | $-119.00 | $-119.00 | $-119.00 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q3 FY2028 | $0.0B | $0.0B | $0.0B | 1 |
| Q2 FY2028 | $0.0B | $0.0B | $0.0B | 1 |
| Q1 FY2028 | $0.0B | $0.0B | $0.0B | 1 |
| Q4 FY2027 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2027 | $0.0B | $0.0B | $0.0B | 1 |
| Q2 FY2027 | $0.0B | $0.0B | $0.0B | 1 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▲ Q2 FY2026 | Apr 1, 2026 | +99.5% | $0.89 | $1.01 | +14.02% |
| — Q1 FY2026 | Mar 25, 2026 | — | $1.02 | $1.14 | +11.76% |
| — Q4 FY2025 | Nov 14, 2025 | — | $2.08 | $1.91 | -8.17% |
| — Q3 FY2025 | Aug 14, 2025 | — | $3.51 | $3.50 | -0.28% |
| — Q2 FY2025 | May 15, 2025 | — | $4.32 | $4.32 | +0.00% |
| ▲ Q1 FY2025 | Mar 21, 2025 | +81.9% | $3.43 | $3.55 | +3.50% |
| ▲ Q4 FY2024 | Nov 14, 2024 | +96.2% | $5.63 | $6.24 | +10.83% |
| ▲ Q3 FY2024 | Aug 14, 2024 | +94.7% | $5.62 | $5.30 | -5.69% |
Q2 FY2026+14.02%
Report Date
Apr 1, 2026
EPS Beat/Miss
+99.5%
Price Before
$0.89
Price After
$1.01
Q1 FY2026+11.76%
Report Date
Mar 25, 2026
EPS Beat/Miss
—
Price Before
$1.02
Price After
$1.14
Q4 FY2025-8.17%
Report Date
Nov 14, 2025
EPS Beat/Miss
—
Price Before
$2.08
Price After
$1.91
Q3 FY2025-0.28%
Report Date
Aug 14, 2025
EPS Beat/Miss
—
Price Before
$3.51
Price After
$3.50
Q2 FY2025+0.00%
Report Date
May 15, 2025
EPS Beat/Miss
—
Price Before
$4.32
Price After
$4.32
Q1 FY2025+3.50%
Report Date
Mar 21, 2025
EPS Beat/Miss
+81.9%
Price Before
$3.43
Price After
$3.55
Q4 FY2024+10.83%
Report Date
Nov 14, 2024
EPS Beat/Miss
+96.2%
Price Before
$5.63
Price After
$6.24
Q3 FY2024-5.69%
Report Date
Aug 14, 2024
EPS Beat/Miss
+94.7%
Price Before
$5.62
Price After
$5.30
Avg Beat Reaction+5.67%
Beat Rate4 / 8 quarters
Largest Move+14.02% (Q2 FY2026)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: TIVC ends December
Tivic Health Systems, Inc. (TIVC) most recently reported earnings on April 1, 2026 for Q2 FY2026, posting EPS of $-2.23 — beating the analyst consensus of $-408.00 by +99.5%. TIVC has beaten EPS estimates for 8 consecutive quarters. The next TIVC earnings date is expected around September 1, 2026.
Each quarter, investors track TIVC earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. TIVC revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
TIVC's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
TIVC earnings · 5 questionsTivic Health Systems, Inc.'s next earnings report is expected around September 1, 2026. TIVC typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; TIVC historically reports after market close (AMC).
TIVC earnings datewhen is TIVC earningsTIVC next earnings datewhen does TIVC report earningsTIVC earnings calendar
▸ Source: FMP · Tivic Health Systems, Inc. SEC filings · US GAAP · Tivic Health Systems, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026